HEMOSONICS, LLC

HEMOSONICS, LLC specializes in the design, development, and manufacturing of advanced viscoelastic testing instrumentation systems for clinical and research applications in surgical and medical environments. Their technical expertise centers on precision medical device engineering, with a focus on point-of-care hemostasis analysis tools that enable real-time assessment of blood clot formation and dissolution. This requires deep competency in fluid dynamics modeling, sensor integration, microfluidics, and FDA-regulated medical device validation processes. The company differentiates itself through its ability to deliver compact, clinically validated instrumentation tailored to the demanding workflows of trauma and surgical care settings, ensuring reliability under high-stakes conditions. The contractor has demonstrated direct experience supporting the Department of Veterans Affairs, providing specialized diagnostic equipment critical to perioperative and transfusion medicine programs. Their work supports VA’s mission to enhance patient outcomes through evidence-based hemostatic management, particularly in veteran populations with complex coagulopathies. The relationship suggests a focus on equipping VA medical centers with next-generation point-of-care diagnostics that reduce reliance on traditional laboratory testing and improve decision-making in time-sensitive surgical and emergency scenarios. HEMOSONICS operates primarily within NAICS 339112, which encompasses the manufacturing of surgical and medical instruments, with a clear vertical specialization in hemostatic diagnostics. Their market positioning is niche but critical, serving the intersection of clinical hematology and surgical instrumentation, where regulatory rigor and functional precision are paramount. The company’s focus on instrumentation rather than reagents or consumables reflects a strategic emphasis on durable, repeat-use medical devices with high clinical utility. As a small business structured as ZZ, HEMOSONICS maintains its operational base in Durham, North Carolina, a hub for biomedical innovation. While no formal government certifications are disclosed, their ability to secure federal contracts implies adherence to stringent quality systems, including ISO 13485 and FDA 21 CFR Part 820 compliance, essential for medical device manufacturers serving the U.S. government.